A CRISPR/Cas9 vector system for tissue-specific gene disruption in zebrafish

Developmental Cell
Julien AblainLeonard I Zon

Abstract

CRISPR/Cas9 technology of genome editing has greatly facilitated the targeted inactivation of genes in vitro and in vivo in a wide range of organisms. In zebrafish, it allows the rapid generation of knockout lines by simply injecting a guide RNA (gRNA) and Cas9 mRNA into one-cell stage embryos. Here, we report a simple and scalable CRISPR-based vector system for tissue-specific gene inactivation in zebrafish. As proof of principle, we used our vector with the gata1 promoter driving Cas9 expression to silence the urod gene, implicated in heme biosynthesis, specifically in the erythrocytic lineage. Urod targeting yielded red fluorescent erythrocytes in zebrafish embryos, recapitulating the phenotype observed in the yquem mutant. While F0 embryos displayed mosaic gene disruption, the phenotype appeared very penetrant in stable F1 fish. This vector system constitutes a unique tool to spatially control gene knockout and greatly broadens the scope of loss-of-function studies in zebrafish.

References

Nov 15, 2000·Genome Research·J L HartleyM A Brasch
Apr 5, 2002·Genome Research·W James Kent
Jul 9, 2004·Developmental Cell·Koichi KawakamiMasayoshi Mishina
Jan 15, 2008·Nature Protocols·Christine Thisse, Bernard Thisse
Nov 29, 2011·Experimental Hematology·Alison M TaylorLeonard I Zon
Apr 28, 2012·Developmental Biology·Jared J GanisLeonard I Zon
Jun 30, 2012·Science·Martin JinekEmmanuelle Charpentier
Jul 14, 2012·Blood·Manisha Balwani, Robert J Desnick
Jan 5, 2013·Science·Le CongFeng Zhang
Jan 5, 2013·Science·Prashant MaliGeorge M Church
Jan 31, 2013·Nature Biotechnology·Woong Y HwangJ Keith Joung
Jan 31, 2013·Nature Biotechnology·Wenyan JiangLuciano A Marraffini
Jan 31, 2013·Nature Biotechnology·Seung Woo ChoJin-Soo Kim
Jun 25, 2013·Nature Biotechnology·Yanfang FuJeffry D Sander
Aug 7, 2013·Proceedings of the National Academy of Sciences of the United States of America·Li-En JaoWenbiao Chen
Dec 18, 2013·Science·Tim WangEric S Lander
Mar 4, 2014·Nature Biotechnology·Jeffry D Sander, J Keith Joung

❮ Previous
Next ❯

Citations

Oct 7, 2015·Nucleic Acids Research·Gaurav K VarshneyShawn M Burgess
Jan 15, 2016·Genomics, Proteomics & Bioinformatics·Dongyuan Ma, Feng Liu
Jan 26, 2016·American Journal of Human Genetics·Ursula M SchickAlex P Reiner
Jul 21, 2016·Current Opinion in Insect Science·William Reid, David A O'Brochta
Jun 14, 2015·Current Opinion in Genetics & Development·Richard M White
Nov 18, 2015·Genesis : the Journal of Genetics and Development·Peggy JungkeMichael Brand
Dec 4, 2015·Cell and Tissue Research·Kevin D Wells
Dec 31, 2015·Nature Methods·Mehmet Fatih BolukbasiScot A Wolfe
Sep 12, 2015·The Journal of Pathology·Louise van der WeydenDavid J Adams
Sep 2, 2015·Seminars in Immunopathology·Annemarie H Meijer
Nov 17, 2015·Nature Biotechnology·James E DiCarloGeorge M Church
Dec 15, 2015·Briefings in Functional Genomics·Robert SertoriClifford Liongue
Nov 27, 2015·Biochimica Et Biophysica Acta·Emily SteedJulien Vermot
Oct 8, 2015·Blood Reviews·Xiangguo ShiAnskar Y H Leung
Mar 27, 2016·Pharmacology & Therapeutics·Gloria R GarciaRobert L Tanguay
Mar 24, 2016·Scientific Reports·Yao ZuWeiming Li
Oct 4, 2015·Trends in Molecular Medicine·Lukas E Dow
Apr 23, 2015·The European Journal of Neuroscience·Cameron WyattEmre Yaksi
Jul 3, 2015·Cell & Bioscience·Sean M RiordanShui Qing Ye
Oct 27, 2015·Brain Research·Sarah D Ackerman, Kelly R Monk
Jun 24, 2016·Journal of Cardiovascular Development and Disease·Daniel R BrownJiandong Liu
May 24, 2016·Journal of Genetics and Genomics = Yi Chuan Xue Bao·Meizhu BaiJinsong Li
Apr 8, 2016·Blood·Megan D Hoban, Daniel E Bauer
Jun 29, 2016·Biochimica Et Biophysica Acta·S Antony CeasarS Ignacimuthu
Oct 28, 2016·Heart Failure Reviews·Despina Bournele, Dimitris Beis
Aug 26, 2016·Immunological Reviews·Theodore GurolQing Deng
Sep 14, 2016·British Journal of Haematology·Han Zhang, Nami McCarty
Oct 1, 2016·Scientific Reports·Irina SedykhYevgenya Grinblat
Oct 31, 2016·Experimental Hematology·Adam P DeveauJason N Berman
Nov 1, 2016·Nature Reviews. Genetics·Benjamin E HousdenNorbert Perrimon
Nov 12, 2016·Trends in Genetics : TIG·Mingyu LiWenbiao Chen
Nov 12, 2016·World Journal of Microbiology & Biotechnology·Amjad Hayat KhanAzam Rahimpour
Jan 6, 2017·Biotechnology & Genetic Engineering Reviews·Amir Roointan, Mohammad Hossein Morowvat
Nov 11, 2016·PloS One·Raymond Teck Ho LeePhilip W Ingham
Jan 26, 2017·Cell Reports·Xiaowen ChenMassimo M Santoro
Apr 8, 2017·Expert Opinion on Drug Discovery·Quinn LuDavid J Dow
May 31, 2017·ACS Synthetic Biology·Michael PinedaSamira Kiani
Apr 6, 2017·Pigment Cell & Melanoma Research·Ellen van RooijenLeonard I Zon

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR Ribonucleases Deactivation

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on mechanisms that underlie deactivation of CRISPR ribonucleases. Here is the latest research.

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.

CRISPR for Genome Editing

Genome editing technologies enable the editing of genes to create or correct mutations. Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). Here is the latest research on the use of CRISPR-Cas system in gene editing.